Some diseases involve autoimmune reactions, when the body begins to attack its own cells and proteins.
CD70 CAR-T by UTC Therapeutics for Burkitt Lymphoma: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes